- Home
- ONTO vs KLTOW Comparison
ONTO vs KLTOW Comparison
Compare ONTO & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONTO | KLTOW |
|---|---|---|
| Founded | 1940 | N/A |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | N/A |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ONTO | KLTOW |
|---|---|---|
| Price | $158.12 | $0.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $155.00 | N/A |
| AVG Volume (30 Days) | ★ 724.8K | N/A |
| Earning Date | 02-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.55 | N/A |
| Revenue | ★ $1,002,336,000.00 | N/A |
| Revenue This Year | $3.72 | N/A |
| Revenue Next Year | $17.29 | N/A |
| P/E Ratio | $44.46 | ★ N/A |
| Revenue Growth | ★ 6.38 | N/A |
| 52 Week Low | $85.88 | N/A |
| 52 Week High | $228.42 | N/A |
Technical Indicators
Market Signals| Indicator | ONTO | KLTOW |
|---|---|---|
| Relative Strength Index (RSI) | 56.53 | 37.45 |
| Support Level | $157.19 | $0.10 |
| Resistance Level | $162.87 | $0.13 |
| Average True Range (ATR) | 5.49 | 0.03 |
| MACD | -0.67 | -0.00 |
| Stochastic Oscillator | 61.36 | 16.77 |
Price Performance
Historical ComparisonAbout ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.